Shin Poong Pharm to present innovative stroke drug ‘SP-8203’ at BIO USA
Shin Poong Pharm(CEO Jae-Man Yoo) will participate in ‘2018 BIO International Convention,’ the world’s largest biopharmaceutical convention held in Boston between 4 and 7 June, and will announce clinical results about its innovative new stroke drug ‘SP-8203’ and results about new drugs that the c...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
